Page last updated: 2024-08-23

androstane-3,17-diol and Polycystic Ovarian Syndrome

androstane-3,17-diol has been researched along with Polycystic Ovarian Syndrome in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19908 (29.63)18.7374
1990's12 (44.44)18.2507
2000's4 (14.81)29.6817
2010's3 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lobo, RA; Saxena, T; Stanczyk, FZ1
Carlsen, SM; Vanky, E1
Holm, G; Janson, PO; Jedel, E; Labrie, F; Lind, AK; Nilsson, L; Odén, A; Ohlsson, C; Stener-Victorin, E1
Andrico, S; Falsetti, L; Gambera, A; Sartori, E1
Tomboc, M; Witchel, SF1
Meczekalski, B; Slopien, R; Warenik-Szymankiewicz, A1
Goebelsmann, U; Horton, R; Lobo, RA1
Lobo, RA; Shoupe, D1
Kuttenn, F; Mauvais-Jarvis, P; Mowszowicz, I1
Bertoli, A; Di Daniele, N; Fusco, A; Gatti, S; Lauro, R; Magnani, A; Marini, MA1
Chang, L; Duffy, DM; Legro, RS; Lobo, RA; Stanczyk, FZ1
Carmina, E; Gentzchein, E; Lobo, RA; Stanczyk, FZ1
De Fusco, D; Falsetti, L; Rosina, B1
Diamanti-Kandarakis, E; Duleba, AJ; Mitrakou, A; Raptis, S; Tolis, G1
Hwang, YY; Roh, JS; Yoo, JB1
Diamandis, EP; Magklara, A; Obiezu, CV; Scorilas, A; Stanczyk, FZ; Thornton, MH; Wang, CY1
Kuttenn, F; Lecomte, P; Mandelbaum, J; Mauvais-Jarvis, P; Mowszowicz, I1
Carmina, E; Cassidenti, DL; Gentzschein, E; Lobo, RA; Miles, RA; Stanczyk, FZ1
Kirschner, MA; Luthold, WW; Marcondes, JA; Minnani, SL; Samojlik, E; Wajchenberg, BL1
de Rooy, HA; Ponjee, GA; Vader, HL1
Giagulli, VA; Giorgino, R; Vermeulen, A1
Blackard, WG; Clore, JN; Matt, DW; Nestler, JE; Plymate, SR; Powers, LP; Rittmaster, RS; Steingold, KA1
Connelly, JF; Davies, HE; Funder, JW; Montalto, J; Yong, AB1
Brailly, S; Couzinet, B; Le Strat, N; Schaison, G1
Lobo, RA; Serafini, P1
Franks, S; James, VH; Reed, MJ; Scanlon, MJ; Whorwood, CB1
Greep, N; Hoopes, M; Horton, R1

Reviews

1 review(s) available for androstane-3,17-diol and Polycystic Ovarian Syndrome

ArticleYear
Hirsutism.
    Monographs on endocrinology, 1981, Volume: 19

    Topics: 17-Ketosteroids; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Cells, Cultured; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Female; Fibroblasts; Hirsutism; Humans; Liver; Male; Metabolic Clearance Rate; Ovarian Neoplasms; Polycystic Ovary Syndrome; Sebaceous Glands; Sex Hormone-Binding Globulin; Skin; Testosterone

1981

Trials

4 trial(s) available for androstane-3,17-diol and Polycystic Ovarian Syndrome

ArticleYear
Metformin influence on hormone levels at birth, in PCOS mothers and their newborns.
    Human reproduction (Oxford, England), 2010, Volume: 25, Issue:3

    Topics: Adult; Androgens; Androstane-3,17-diol; Estradiol; Estrone; Female; Fetal Blood; Humans; Hypoglycemic Agents; Infant, Newborn; Male; Metformin; Polycystic Ovary Syndrome; Pregnancy; Sex Hormone-Binding Globulin; Testosterone

2010
Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.
    American journal of physiology. Endocrinology and metabolism, 2011, Volume: 300, Issue:1

    Topics: Acneiform Eruptions; Adolescent; Adult; Amenorrhea; Androstane-3,17-diol; Androsterone; Combined Modality Therapy; Electroacupuncture; Exercise; Female; Humans; Hyperandrogenism; Menstrual Cycle; Motor Activity; Oligomenorrhea; Polycystic Ovary Syndrome; Severity of Illness Index; Testosterone; Time Factors; Young Adult

2011
Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1995, Volume: 103, Issue:1

    Topics: Adolescent; Adult; Androstane-3,17-diol; Androstenedione; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Hirsutism; Humans; Luteinizing Hormone; Menstruation Disturbances; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors

1995
Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 63, Issue:4

    Topics: Adult; Androstane-3,17-diol; Androstenedione; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Estradiol; Estrone; Female; Gonadotropin-Releasing Hormone; Humans; Polycystic Ovary Syndrome; Testosterone; Triptorelin Pamoate

1986

Other Studies

22 other study(ies) available for androstane-3,17-diol and Polycystic Ovarian Syndrome

ArticleYear
Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    The Journal of steroid biochemistry and molecular biology, 2014, Volume: 139

    Topics: Adrenal Glands; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Androsterone; Case-Control Studies; Dehydroepiandrosterone Sulfate; Dexamethasone; Female; Humans; Hyperandrogenism; Ovary; Polycystic Ovary Syndrome; Testosterone; Treatment Outcome

2014
Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2002, Volume: 16, Issue:4

    Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Amenorrhea; Androstane-3,17-diol; Androstenedione; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Hirsutism; Humans; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Luteinizing Hormone; Obesity; Oligomenorrhea; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography

2002
Frequencies of the D85 and Y85 variants of UGT2B15 in children and adolescent girls with hyperandrogenism.
    Journal of pediatric endocrinology & metabolism : JPEM, 2003, Volume: 16, Issue:5

    Topics: Adolescent; Androstane-3,17-diol; Androstenedione; Child; Dihydrotestosterone; Female; Gene Frequency; Genotype; Glucuronosyltransferase; Heterozygote; Homozygote; Humans; Hyperandrogenism; Phenotype; Polycystic Ovary Syndrome; Puberty, Precocious; Sex Hormone-Binding Globulin; Testosterone

2003
Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    European journal of obstetrics, gynecology, and reproductive biology, 2007, Volume: 132, Issue:1

    Topics: Adolescent; Adult; Androstane-3,17-diol; Biomarkers; Body Mass Index; Case-Control Studies; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Testosterone

2007
Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    The Journal of clinical endocrinology and metabolism, 1983, Volume: 57, Issue:2

    Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Androstanols; Androstenediol; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Testosterone

1983
The influence of androgens on insulin resistance.
    Fertility and sterility, 1984, Volume: 41, Issue:3

    Topics: Adult; Androgens; Androstane-3,17-diol; Dehydroepiandrosterone; Dihydrotestosterone; Female; Hirsutism; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Pituitary Hormone-Releasing Hormones; Polycystic Ovary Syndrome; Spironolactone; Testosterone

1984
Metabolism of dihydrotestosterone to 5 alpha-androstane-3 alpha, 17 beta-diol glucuronide is greater in the peripheral compartment than in the splanchnic compartment.
    Fertility and sterility, 1995, Volume: 64, Issue:4

    Topics: Administration, Cutaneous; Adolescent; Adult; Androstane-3,17-diol; Androsterone; Dihydrotestosterone; Female; Hirsutism; Humans; Infusions, Intravenous; Male; Middle Aged; Polycystic Ovary Syndrome; Prospective Studies; Reference Values; Splanchnic Circulation

1995
Time-dependent changes in serum 3 alpha-androstanediol glucuronide correlate with hirsutism scores after ovarian suppression.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1995, Volume: 9, Issue:3

    Topics: Adult; Androstane-3,17-diol; Androsterone; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Testosterone; Triptorelin Pamoate

1995
Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women.
    European journal of endocrinology, 1998, Volume: 138, Issue:4

    Topics: Adolescent; Adult; Androstane-3,17-diol; Case-Control Studies; Female; Hirsutism; Humans; Hyperandrogenism; Obesity; Polycystic Ovary Syndrome

1998
The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:8

    Topics: Adult; Androgen Antagonists; Androstane-3,17-diol; Androstenedione; Cholesterol; Dehydroepiandrosterone Sulfate; Female; Flutamide; Humans; Hyperlipidemias; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Liver Function Tests; Obesity; Polycystic Ovary Syndrome; Testosterone; Triglycerides

1998
Increased peripheral androgen activity in infertile Korean women with polycystic ovaries.
    Human reproduction (Oxford, England), 1999, Volume: 14, Issue:8

    Topics: Adult; Androstane-3,17-diol; Female; Humans; Infertility, Female; Korea; Luteinizing Hormone; Polycystic Ovary Syndrome; Ultrasonography

1999
Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:4

    Topics: Adult; Androstane-3,17-diol; Case-Control Studies; Female; Humans; Polycystic Ovary Syndrome; Prostate-Specific Antigen; Reference Values; Testosterone; Tissue Kallikreins

2001
[12 cases of polycystic ovary type 1 (Stein-Leventhal syndrome): complete hormonal study (author's transl)].
    Annales d'endocrinologie, 1978, Volume: 39, Issue:3

    Topics: Androstane-3,17-diol; Androstenedione; Clomiphene; Dihydrotestosterone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Pregnancy; Testosterone

1978
Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.
    Fertility and sterility, 1992, Volume: 58, Issue:4

    Topics: Administration, Cutaneous; Adult; Androstane-3,17-diol; Androstenedione; Androsterone; Cholestenone 5 alpha-Reductase; Female; Gels; Hirsutism; Humans; Male; Oxidoreductases; Polycystic Ovary Syndrome

1992
Treatment of hirsutism in women with flutamide.
    Fertility and sterility, 1992, Volume: 57, Issue:3

    Topics: Adult; Analysis of Variance; Androstane-3,17-diol; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome

1992
Androstanediolglucuronide: a parameter for peripheral androgen activity before and during therapy with cyproterone acetate.
    Acta endocrinologica, 1991, Volume: 124, Issue:4

    Topics: Androgen Antagonists; Androgens; Androstane-3,17-diol; Cyproterone; Cyproterone Acetate; Female; Hirsutism; Humans; Polycystic Ovary Syndrome

1991
Is plasma 5 alpha-androstane 3 alpha, 17 beta-diol glucuronide a biochemical marker of hirsutism in women?
    The Journal of steroid biochemistry and molecular biology, 1991, Volume: 39, Issue:1

    Topics: Adult; Androgen Antagonists; Androstane-3,17-diol; Biomarkers; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Polycystic Ovary Syndrome

1991
A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:1

    Topics: Adult; Androstane-3,17-diol; Androstenedione; Diazoxide; Estradiol; Estrone; Female; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Humans; Insulin; Insulin Resistance; Leuprolide; Obesity; Polycystic Ovary Syndrome; Progesterone; Sex Hormone-Binding Globulin; Testosterone

1991
Serum 5-androstene-3 beta,17 beta-diol sulphate and 5 alpha-androstane-3 alpha,17 beta-diol sulphate in hirsute females with polycystic ovarian disease.
    Journal of steroid biochemistry, 1990, Volume: 36, Issue:1-2

    Topics: Adult; Androgens; Androstane-3,17-diol; Androstanols; Androstenediol; Androstenediols; Female; Hirsutism; Humans; In Vitro Techniques; Polycystic Ovary Syndrome; Radioimmunoassay; Sex Hormone-Binding Globulin

1990
Increased 5 alpha-reductase activity in idiopathic hirsutism.
    Fertility and sterility, 1985, Volume: 43, Issue:1

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Androstane-3,17-diol; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Genitalia, Female; Hirsutism; Humans; Luteinizing Hormone; Oxidoreductases; Polycystic Ovary Syndrome; Skin; Testosterone

1985
Serum androstanediol glucuronide concentrations in normal and hirsute women and patients with thyroid dysfunction.
    Clinical endocrinology, 1988, Volume: 29, Issue:5

    Topics: Adult; Androstane-3,17-diol; Androstanols; Body Height; Body Weight; Contraceptives, Oral; Dihydrotestosterone; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Thyroid Diseases

1988
Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 62, Issue:1

    Topics: Adult; Androstane-3,17-diol; Androstanols; Female; Hirsutism; Humans; Kinetics; Metabolic Clearance Rate; Polycystic Ovary Syndrome; Reference Values; Tritium

1986